265 related articles for article (PubMed ID: 12573815)
1. Androgen receptor mutations and androgen insensitivity.
McPhaul MJ
Mol Cell Endocrinol; 2002 Dec; 198(1-2):61-7. PubMed ID: 12573815
[TBL] [Abstract][Full Text] [Related]
2. Molecular defects of the androgen receptor.
McPhaul MJ
Recent Prog Horm Res; 2002; 57():181-94. PubMed ID: 12017542
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of androgen insensitivity.
Brinkmann AO
Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
[TBL] [Abstract][Full Text] [Related]
4. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.
Avila DM; Zoppi S; McPhaul MJ
J Steroid Biochem Mol Biol; 2001; 76(1-5):135-42. PubMed ID: 11384871
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays.
Avila DM; Wilson CM; Nandi N; Griffin JE; McPhaul MJ
J Clin Endocrinol Metab; 2002 Jan; 87(1):182-8. PubMed ID: 11788645
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance.
McPhaul MJ; Marcelli M; Zoppi S; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1993 Jan; 76(1):17-23. PubMed ID: 8421085
[TBL] [Abstract][Full Text] [Related]
7. Molecular defects of the androgen receptor.
McPhaul MJ
J Steroid Biochem Mol Biol; 1999; 69(1-6):315-22. PubMed ID: 10419008
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor gene and male infertility.
Yong EL; Loy CJ; Sim KS
Hum Reprod Update; 2003; 9(1):1-7. PubMed ID: 12638777
[TBL] [Abstract][Full Text] [Related]
10. Genotype versus phenotype in families with androgen insensitivity syndrome.
Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
[TBL] [Abstract][Full Text] [Related]
11. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743.
Poujol N; Lumbroso S; Térouanne B; Lobaccaro JM; Bourguet W; Sultan C
J Clin Endocrinol Metab; 2002 Dec; 87(12):5793-800. PubMed ID: 12466388
[TBL] [Abstract][Full Text] [Related]
13. Mutations of androgen receptor gene in androgen insensitivity syndromes.
Sultan C; Lumbroso S; Poujol N; Belon C; Boudon C; Lobaccaro JM
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):519-30. PubMed ID: 8240973
[TBL] [Abstract][Full Text] [Related]
14. In vitro functional characterization of androgen receptor gene mutations at arginine p.856 of the ligand-binding-domain associated with androgen insensitivity syndrome.
Tajouri A; Kharrat M; Trabelsi M; M'rad R; Hiort O; Werner R
J Steroid Biochem Mol Biol; 2021 Apr; 208():105834. PubMed ID: 33548461
[TBL] [Abstract][Full Text] [Related]
15. Frame-shift mutation in hormone binding domain of human androgen receptor gene causes complete androgen insensitivity.
Chung HW; Kim SC; Kim HL
Mol Cells; 1998 Dec; 8(6):741-5. PubMed ID: 9895128
[TBL] [Abstract][Full Text] [Related]
16. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
[TBL] [Abstract][Full Text] [Related]
17. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
[TBL] [Abstract][Full Text] [Related]
18. Physiology and pathophysiology of androgen action.
Hiort O; Holterhus PM; Nitsche EM
Baillieres Clin Endocrinol Metab; 1998 Apr; 12(1):115-32. PubMed ID: 9890064
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of androgen insensitivity.
Nitsche EM; Hiort O
Horm Res; 2000; 54(5-6):327-33. PubMed ID: 11595828
[TBL] [Abstract][Full Text] [Related]
20. Androgen insensitivity syndrome.
Hughes IA; Werner R; Bunch T; Hiort O
Semin Reprod Med; 2012 Oct; 30(5):432-42. PubMed ID: 23044881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
